Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026)

Odyssey Health (ODYY) reported Total Non-Current Liabilities of $7.7 million for Q2 2026, up 4.23% sequentially from $7.4 million in Q1 2026.

Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends

Odyssey Health has disclosed Total Non-Current Liabilities across 4 years of filings, most recently posting $7.7 million for Q2 2026.

Quarterly Total Non-Current Liabilities changed N/A year-over-year to $7.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $7.7 million (changed N/A YoY) and the FY2025 annual result came in at $7.0 million, changed N/A from the prior year.
Total Non-Current Liabilities advanced to $7.7 million in Q2 2026, from $7.4 million in the prior quarter.
Across five years, Total Non-Current Liabilities topped out at $7.7 million in Q2 2026 and bottomed at $7.0 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Non-Current Liabilities (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	-
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	20.94 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	40.52 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	15.78 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	2.44 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.85 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	3.53 Bn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	24.21 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	3.47 Bn
10	Odyssey Health	-	-	-	7.69 Mn

Download Data